What is ResMed Inc.'s market cap?

ResMed Inc. (RMD) has a market capitalization of $34.0B and trades on NYSE.

What is ResMed Inc.'s revenue and profitability?

ResMed Inc. generated $5.7B in trailing twelve-month revenue with net income of $1.5B, representing a net margin of 26.9%. Gross margin stands at 61.1%, with free cash flow of $1.6B. These figures are based on the Q2 2026 filing.

Who are ResMed Inc.'s competitors?

ResMed Inc.'s key competitors include Philips, Fisher & Paykel Healthcare, Inspire Medical Systems, and others. These companies compete in similar markets and product categories.

Who does ResMed Inc. partner with?

ResMed Inc.'s notable partners include Baxter.

What subsidiaries does ResMed Inc. have?

ResMed Inc.'s subsidiaries include Brightree, MEDIFOX DAN, Noctrix Health, LLC, and others.

Where is ResMed Inc. headquartered?

ResMed Inc. is headquartered in United States of America and employs approximately 10,140 people. It has been publicly traded since 1995.

ResMed Inc. (RMD) Stock Fundamentals & Financials

ResMed Inc. is a global leader in digital health and cloud-connected medical devices, specializing in the treatment of sleep-disordered breathing and chronic respiratory diseases.

Market cap

$34B-17.6%

Revenue$5.7B+9.9%

Net income$1.5B+8.8%

Free cash flow$1.6B-0.7%

EPS (diluted)$10.43+9.7%

Trailing twelve months · change vs. prior year

Earnings

Q4 2026 report

August 6, 2026

Revenue$1.5BBeat by $2.3M EPS$2.95Beat by $0.06

Read the full report

Next report

Oct 29, 2026 (in 2 months)

Revenue estimate$1.4B

EPS estimate$2.69

Financials

Q4 2026

Income statement

See full

Revenue$1.5B+8.6%

Gross profit$861.2M+5.0%

Operating income$448.7M-1.3%

Net income$383.4M+1.0%

EPS (diluted)$2.64+2.3%

Balance sheet

See full

Cash & equivalents$1.5B+21.5%

Total debt$825.9M-4.2%

Total equity$6.6B+10.3%

Total assets$9.0B+9.7%

Cash flow

See full

Operating cash flow$454.6M-15.6%

CapEx$51.1M+67.2%

Free cash flow$403.5M-20.6%

Valuation & ratios

Valuation

See full

Market cap$34B-17.6%

Enterprise value$33.36B-18.5%

P/E22.3×-7.2×

P/S6×-2.0×

Profitability

See full

Gross margin61.1%+1.7pp

Operating margin33.4%+0.6pp

Net margin26.9%-0.3pp

FCF margin29.2%-3.1pp

Returns & leverage

See full

Return on equity24.3%-1.6pp

Debt / equity0.1×0.0×

Current ratio3.1×-0.3×

Segments

By segment

See full

Sleep and Breathing Health$1.3B+9.4%

Residential Care Software$171.9M+2.9%

By product

See full

Sleep and Breathing Health$1.3B+9.4%

Residential Care Software$171.9M+2.9%

Competitors

By market cap

ResMed Inc.$34.0B-17.6%

GE HealthCare Technologies$33.1B-2.3%

Philips$26.4B+0.2%

Inspire Medical Systems$1.8B-34.5%

AdaptHealth$756.4M-39.3%

Five Point Holdings, Inc.$366.2M-6.8%

Viemed Healthcare, Inc.$355.4M+27.6%

Vivos Therapeutics, Inc.$5.1M-85.2%

By revenue growth

Viemed Healthcare, Inc.+23.1%

ResMed Inc.+9.9%

Inspire Medical Systems+8.9%

GE HealthCare Technologies+6.5%

AdaptHealth+1.2%

Five Point Holdings, Inc.-40.8%

By net margin

Five Point Holdings, Inc.45.34%+5.9pp

ResMed Inc.26.94%-0.3pp

Inspire Medical Systems14.33%+6.4pp

GE HealthCare Technologies9.33%-1.9pp

Viemed Healthcare, Inc.5.2%-0.1pp

AdaptHealth-2.42%-5.0pp

Profile

ResMed Inc. is a global leader in digital health and cloud-connected medical devices, specializing in the treatment of sleep-disordered breathing and chronic respiratory diseases. The company designs and manufactures innovative hardware and software solutions that facilitate home-based healthcare, improve patient adherence to therapy, and lower overall costs for healthcare systems. Its ecosystem integrates AI-powered digital health applications with life-support and ventilation devices to manage chronic conditions more effectively.

Competitive position

ResMed is a dominant global leader in the sleep apnea market with a significant first-mover advantage in cloud-connected medical devices and integrated digital health ecosystems.

GeographiesUnited States, Germany, Australia, Global

Customer segmentsHealthcare Providers, Patients, Residential Care Facilities

Business modelManufacturing, Subscription SaaS, Software-enabled services

SuppliersElectronic component manufacturers, Medical-grade plastic suppliers, Software developers, Cloud infrastructure providers

CustomersHome medical equipment distributors, Sleep clinics, Hospitals, Direct-to-consumer patients

CountryUnited States of America

Listed1995

Employees10.1K

CEOMichael J. Farrell

SectorHealthcare

IndustryMedical - Instruments & Supplies

Websiteresmed.com

FilingsSEC EDGAR

FAQ

What is ResMed Inc.'s market cap?: ResMed Inc. (RMD) has a market capitalization of $34.0B and trades on NYSE.
What is ResMed Inc.'s revenue and profitability?: ResMed Inc. generated $5.7B in trailing twelve-month revenue with net income of $1.5B, representing a net margin of 26.9%. Gross margin stands at 61.1%, with free cash flow of $1.6B. These figures are based on the Q2 2026 filing.
Who are ResMed Inc.'s competitors?: ResMed Inc.'s key competitors include Philips, Fisher & Paykel Healthcare, Inspire Medical Systems, and others. These companies compete in similar markets and product categories.
Who does ResMed Inc. partner with?: ResMed Inc.'s notable partners include Baxter.
What subsidiaries does ResMed Inc. have?: ResMed Inc.'s subsidiaries include Brightree, MEDIFOX DAN, Noctrix Health, LLC, and others.
Where is ResMed Inc. headquartered?: ResMed Inc. is headquartered in United States of America and employs approximately 10,140 people. It has been publicly traded since 1995.

Ask your AI about ResMed Inc..

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude